Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)
CNY 10.8
(-0.55%)
CNY 10.8
(-0.55%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CNY | -100.0% |
| 2022 | 3.17 Million CNY | -40.82% |
| 2021 | 5.37 Million CNY | -31.18% |
| 2020 | 7.8 Million CNY | 1.66% |
| 2019 | 7.67 Million CNY | -32.16% |
| 2018 | 11.31 Million CNY | -22.77% |
| 2017 | 14.65 Million CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | -100.0% |
| 2014 | 1.00 CNY | 100.0% |
| 2013 | -7.18 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 67.5 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 59.74 Thousand CNY | 0.0% |
| 2024 Q2 | 59.24 Thousand CNY | 0.0% |
| 2024 Q1 | - CNY | 0.0% |
| 2023 Q3 | - CNY | 0.0% |
| 2023 FY | - CNY | -100.0% |
| 2023 Q4 | - CNY | -100.0% |
| 2023 Q2 | - CNY | -100.0% |
| 2023 Q1 | 2.43 Million CNY | -23.49% |
| 2022 Q3 | 3.93 Million CNY | -10.01% |
| 2022 Q1 | 4.75 Million CNY | -11.54% |
| 2022 Q2 | 4.37 Million CNY | -7.91% |
| 2022 FY | 3.17 Million CNY | -40.82% |
| 2022 Q4 | 3.17 Million CNY | -19.27% |
| 2021 Q2 | 6.6 Million CNY | -8.08% |
| 2021 Q4 | 5.37 Million CNY | -11.18% |
| 2021 FY | 5.37 Million CNY | -31.18% |
| 2021 Q3 | 6.04 Million CNY | -8.37% |
| 2021 Q1 | 7.18 Million CNY | 718050000.0% |
| 2020 FY | 7.8 Million CNY | 1.66% |
| 2020 Q1 | 7.74 Million CNY | 0.89% |
| 2020 Q2 | 7.81 Million CNY | 0.88% |
| 2020 Q3 | 3.29 Million CNY | -57.88% |
| 2020 Q4 | 1.00 CNY | -100.0% |
| 2019 FY | 7.67 Million CNY | -32.16% |
| 2019 Q4 | 7.67 Million CNY | 0.9% |
| 2019 Q3 | 7.6 Million CNY | -33.94% |
| 2019 Q1 | 11.41 Million CNY | 0.89% |
| 2019 Q2 | 11.51 Million CNY | 0.88% |
| 2018 Q2 | 14.65 Million CNY | 0.0% |
| 2018 Q1 | 14.65 Million CNY | 0.0% |
| 2018 Q4 | 11.31 Million CNY | -29.62% |
| 2018 Q3 | 16.07 Million CNY | 9.73% |
| 2018 FY | 11.31 Million CNY | -22.77% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | 14.65 Million CNY | 0.0% |
| 2017 Q4 | 14.65 Million CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | -100.0% |
| 2015 FY | - CNY | -100.0% |
| 2015 Q1 | 1.00 CNY | 0.0% |
| 2015 Q2 | 1.00 CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q4 | 1.00 CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 FY | 1.00 CNY | 100.0% |
| 2014 Q1 | - CNY | 100.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 Q3 | 1.00 CNY | 0.0% |
| 2013 FY | -7.18 Million CNY | 0.0% |
| 2013 Q4 | -7.18 Million CNY | -718498100.0% |
| 2013 Q2 | 1.00 CNY | 0.0% |
| 2013 Q1 | 1.00 CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 FY | - CNY | -100.0% |
| 2011 Q2 | - CNY | -100.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q1 | 77.5 Million CNY | 14.81% |
| 2010 Q4 | 67.5 Million CNY | -12.9% |
| 2010 FY | 67.5 Million CNY | 0.0% |
| 2010 Q3 | 77.5 Million CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |